The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Official Title: A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Study ID: NCT01844986
Brief Summary: Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy.
Detailed Description: A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Clearview Cancer Institute, Huntsville, Alabama, United States
Providence Cancer Center, Anchorage, Alaska, United States
St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
University of California, Los Angeles, Los Angeles, California, United States
Kaiser Permanente, Oakland, California, United States
Kaiser Permanente, Roseville, California, United States
Stanford Women's Cancer Center, Stanford, California, United States
Babak Edraki, Walnut Creek, California, United States
University of Colorado, Aurora, Colorado, United States
Univ of Connecticut Health Center, Farmington, Connecticut, United States
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States
Florida Hospital Cancer Institute, Orlando, Florida, United States
Gynecologic Cancer Center, Orlando, Florida, United States
H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Northside Hospital, Atlanta, Georgia, United States
Northeast Georgia Medical Center, Gainesville, Georgia, United States
Nancy N. & J.C. Lewis Cancer and Research Pavillion, Savannah, Georgia, United States
The Queen's Medical Center, Honolulu, Hawaii, United States
University of Hawaii, Honolulu, Hawaii, United States
Northwestern University, Chicago, Illinois, United States
Univ Chicago Medical Center, Chicago, Illinois, United States
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States
Indiana University, Indianapolis, Indiana, United States
St. Vincent Hospital & Health Care Center, Indianapolis, Indiana, United States
Northern Indiana Cancer Research Consortium, Mishawaka, Indiana, United States
McFarland Clinic, P.C., Ames, Iowa, United States
Norton Cancer Institute Research, Louisville, Kentucky, United States
Maine Medical Partners, Scarborough, Maine, United States
Greater Baltimore Medical Center, Baltimore, Maryland, United States
Johns Hopkins, Baltimore, Maryland, United States
Walter Reed National Military Medical Center, Bethesda, Maryland, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Henry Ford Health System, Detroit, Michigan, United States
Gynecologic Oncology of West MI, PLLC, Grand Rapids, Michigan, United States
Minnesota Oncology Hematology, PA, Edina, Minnesota, United States
Mayo Clinic - Rochester, MN, Rochester, Minnesota, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Missouri Valley Cancer Consortium CCOP, Omaha, Nebraska, United States
Nebraska Methodist Hospital, Omaha, Nebraska, United States
Womens Cancer Center of Nevada, Las Vegas, Nevada, United States
MD Anderson at Cooper Cancer Center, Camden, New Jersey, United States
John Theurer Cancer Center, Hackensack, New Jersey, United States
University of New Mexico, Albuquerque, New Mexico, United States
Women's Cancer Care Associates, Albany, New York, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Mount Sinai Medical Center - New York, New York, New York, United States
Perlmutter Cancer Center, New York, New York, United States
Hope Women's Cancer Centers, Asheville, North Carolina, United States
UNC Chapel Hill, Chapel Hill, North Carolina, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
Duke University Medical Center, Durham, North Carolina, United States
Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States
Aultman Hospital, Canton, Ohio, United States
Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland, Ohio, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
University Hospital Case Medical Center, Cleveland, Ohio, United States
Research Site, Columbus, Ohio, United States
Kettering Medical Center, Kettering, Ohio, United States
Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, United States
Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Abington Memorial Hospital, Abington, Pennsylvania, United States
St. Luke's University Health Network, Bethlehem, Pennsylvania, United States
The University of Pennsylvania, Philadelphia, Pennsylvania, United States
Women and Infants Hospital, Providence, Rhode Island, United States
South Carolina Oncology Associates, PA, Columbia, South Carolina, United States
Avera Cancer Institute, Sioux Falls, South Dakota, United States
Sanford Clinic Women's Health, Sioux Falls, South Dakota, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
University of Texas Health Science Center of Houston, Houston, Texas, United States
University of Virginia, Charlottesville, Virginia, United States
Virginia Oncology Associates, Norfolk, Virginia, United States
Carilion Clinic Gynecological Oncology, Roanoke, Virginia, United States
Aurora Baycare Medical Center, Green Bay, Wisconsin, United States
University of Wisconsin-Madison, Madison, Wisconsin, United States
Froedtert Memorial Hospital, Milwaukee, Wisconsin, United States
Mercy Hospital for Women, Heidelberg, , Australia
The Royal Womens Hospital, Parkville, , Australia
Prince of Wales Hospital, Randwick, , Australia
Centro Diagnóstico Barretos, Barretos, , Brazil
Hospital Araujo Jorge, Goiânia, , Brazil
Centro de Novos Tratamentos Itajai, Itajai, , Brazil
Hospital de Clinicas de Porto Alegre, Porto Alegre, , Brazil
Irmandade da Santa Casa de Misericordia de Porto Alagre, Porto Alegre, , Brazil
Hospital de Base São José do Rio Preto, São José do Rio Preto, , Brazil
Centro de Referencia da Saude da Mulher, São Paulo, , Brazil
Instituto do Câncer de São Paulo, São Paulo, , Brazil
Juravinski Cancer Centre, Hamilton, Ontario, Canada
London Health Sciences Centre, London, Ontario, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Sunnybrook Health Sciences Center, Toronto, Ontario, Canada
CHUM - Hopital Norte-Dame, Montreal, Quebec, Canada
Royal Victoria Hospital, Montreal, Quebec, Canada
Hotel-Dieu de Quebec, Quebec, , Canada
Beijing Cancer Hospital, Beijing, , China
The Tumor Hospital affiliated to China Medical Science Insti, Beijing, , China
1st Hospital of Jilin university, Changchun, , China
Jilin Provincial Cancer Hospital, Changchun, , China
Hunan Cancer Hospital, Changsha, , China
West China Hospital Affiliated to Sichuan University, Chengdu, , China
ChongQing Cancer Hospital, Chongqing, , China
Research Site, Guangzhou, , China
Women's Hospital, Zhejaing University School of Medicine, Hangzhou, , China
The Tumour Hospital of Harbin Medical University, Harbin, , China
Zhejiang Cancer Hospital, Huangzhou, Huangzhou, , China
JINAN, Qi Lu Hosp. of SD Univ., Ji Nan, , China
Obstetris and Gynecology Hospital of Fudan University, Shanghai, , China
Shanghai Cancer Hospital of Fudan University, Shanghai, , China
The First Affiliated Hospital of Soochow Universit, Suzhou, , China
First affiliated hospital college of XianJiaotong University, Xian, , China
Institut Bergonie, Bordeaux, , France
CAC François Baclesse, Caen Cedex, , France
69LYON, C Bérard, Onco, Lyon Cedex 08, , France
Centre Catherine de Sienne, Nantes,, , France
75PARIS, H Tenon, Onco, Paris, , France
Centre Alexis Vautrin, Vandoeuvre Les Nancy, , France
Institut Gustave Roussy, Villejuif Cedex, , France
Rambam Health Care Campus, Haifa, , Israel
Sapir Medical Centre, Kfar Saba, , Israel
Rabin MC, Petach Tikva, , Israel
Chaim Sheba Medical Centre, Tel Hashomer, , Israel
Tel-Aviv Sourkasy Medical Center, Tel-Aviv, , Israel
Bari- Istituto Tumori Giovanni Paolo II, Bari, , Italy
Azienda Ospedaliera "Cannizzaro", Catania, , Italy
Istituto Europeo di Oncologia, Milano, , Italy
Istituto Nazionale Per Cura Tumori - Milano, Milano, , Italy
Istituto Nazionale Tumori Fondazione Pascale, Napoli, , Italy
Istituto Oncologico Veneto Irccs, Padova, , Italy
Istituto Regina Elena-Polo Oncologico Ifo, Roma, , Italy
Policlinico Universitario A. Gemelli, Roma, , Italy
Hyogo CC, Akashi-shi, , Japan
National Cancer Center Hosp, Chuo-ku, , Japan
NHO Kyushu CC, Fukuoka, , Japan
Saitama Med. Univ. Int. Med. C, Hidaka-shi, , Japan
NHO Shikoku Cancer Center, Matsuyama-shi, , Japan
Niigata Univ. Med. Dent., Niigata-shi, , Japan
Hokkaido University Hospital, Sapporo-shi, , Japan
Shizuoka Cancer Center, Sunto-gun, , Japan
National Cancer Center, Goyang-si, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Gangnam Severance Hospital, Seoul, , Korea, Republic of
Korea Cancer Center Hospital, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, , Netherlands
Maastricht Universitair Medisch Centrum, Maastricht, , Netherlands
Niepubliczny Zaklad Opieki Zdrowotnej Innowacyjna Medycyna, Grzepnica, , Poland
SPZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii, Olsztyn, , Poland
Wojewódzki Szpital Specjalistyczny w Olsztynie, Olsztyn, , Poland
Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warszawa, , Poland
Szpital Specjalistyczny im. Swietej Rodziny SPZOZ, Warszawa, , Poland
Udmurtia Republic Clinical Oncology Center, Izhevsk, , Russian Federation
Chemotherapy Department, Russian Cancer Research Centre, Moscow, , Russian Federation
State Institution of Heath Omsk Regional Oncology Dispensary, Omsk, , Russian Federation
Cancer Research Institute, Saint Petersburg, , Russian Federation
St.Petersburg City Oncology Dispensary, Dept. Gynecology, Saint Petersburg, , Russian Federation
Leningrad Regional Oncology Dispensary, St.Petersburg, , Russian Federation
Research Institute of Oncology RAMS, Tomsk, , Russian Federation
Barcelona,H.Vall d´Hebrón,Oncología, Barcelona, , Spain
Córdoba,H.Reina Sofía,Oncología, Córdoba, , Spain
H.Llobregat,ICO-Duran i Reynals,Oncología, Hospitalet deLlobregat(Barcelo, , Spain
Madrid, MD Anderson, Oncología, Madrid, , Spain
Madrid,H.U.La Paz,Oncología, Madrid, , Spain
Valencia, IVO, Oncología, Valencia, , Spain
Valencia,H.C.U.Valencia,Oncología, Valencia, , Spain
City Hospital, Birmingham, Cancer Trials Team, Birmingham, , United Kingdom
Addenbrooke's Hospital, Cambridge, , United Kingdom
Arden Cancer Centre, Coventry, , United Kingdom
Edinburgh Cancer Research UK Centre, Edinburgh, , United Kingdom
Cancer Research UK and UCL Cancer Trials Centre, London, , United Kingdom
Royal Marsden Hospital, London, , United Kingdom
Royal Marsden Hospital and Institute of Cancer Research, Sutton, , United Kingdom
Name: Prof Paul DiSilvestro, MD
Affiliation: Women & Infants Hospital, Providence, Rhode Island, USA
Role: PRINCIPAL_INVESTIGATOR
Name: Prof Kathleen Moore, MD
Affiliation: University of Oklahoma Health Sciences Center, Oklahoma City, USA
Role: PRINCIPAL_INVESTIGATOR